ETX-018810

DRUG2 trials

Sponsors

Eliem Therapeutics (UK) Ltd.

Conditions

Diabetic Peripheral Neuropathic PainDiabetic Peripheral NeuropathyLumbosacral Radiculopathy

Phase 2

Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain

CompletedNCT04688671

Eliem Therapeutics (UK) Ltd.Diabetic Peripheral Neuropathic Pain, Diabetic Peripheral Neuropathy

Start: 2020-11-09End: 2022-02-18Updated: 2023-11-07

Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain

CompletedNCT04778592

Eliem Therapeutics (UK) Ltd.Lumbosacral Radiculopathy

Start: 2021-01-19End: 2022-05-25Updated: 2023-11-07